Technology

AddToAny

Google+ Facebook Twitter Twitter

Diagnostics range launch

Horiba Medical UK has announced a significant development of its in vitro diagnostics product offering with the launch of its new Yumizen G range of instruments and reagents.

Marking a milestone in its new product development programme, the Yumizen G range extends Horiba Medical’s Haematology portfolio into the complementary field of Haemostasis – a new discipline for the company.

Horiba Medical has developed a reputation for expertise and excellence in blood cell analysis. This has been utilised to deliver the new and comprehensive range of Yumizen G systems and reagents for coagulation diagnostics.

Cleve Wright, Director of Horiba Medical UK, said: “By leveraging our extensive expertise in the Haematology field, we have significantly broadened our scope in blood disease analysis into a complementary discipline.”

horiba.com/uk/medical

Related Articles

Blood test for Alzheimer’s

Randall Bateman is leading a team that has just come up with a blood test to screen people at risk of developing Alzheimer’s disease, years before the symptoms appear. 

September news in numbers

A breakdown of science news this month, in numbers.

Laboratory errors in transfusion

Jenny Berryman and Paula Bolton-Maggs from the Serious Hazards of Transfusion (SHOT) scheme explain their latest annual report.

news_in_numbers.png

August news in numbers

A breakdown of science news this month, in numbers.

Top